191 related articles for article (PubMed ID: 38291338)
21. LncRNA DLEU2 promotes tumour growth by sponging miR-337-3p in human osteosarcoma.
Liu W; Liu PC; Ma K; Wang YY; Chi QB; Yan M
Cell Biochem Funct; 2020 Oct; 38(7):886-894. PubMed ID: 32196715
[TBL] [Abstract][Full Text] [Related]
22. LncRNA DLEU2 regulates sirtuins and mitochondrial respiratory chain complex IV: a novel pathway in obesity and offspring's health.
Zhang J; Kay MK; Park MH; Meruvu S; Powell C; Choudhury M
Int J Obes (Lond); 2022 May; 46(5):969-976. PubMed ID: 35058572
[TBL] [Abstract][Full Text] [Related]
23. Primaquine elicits Foxp3
Thome R; Casella G; Lotfi N; Ishikawa LWL; Wang Q; Ciric B; Zhang GX; Rostami A
J Autoimmun; 2020 Nov; 114():102505. PubMed ID: 32595012
[TBL] [Abstract][Full Text] [Related]
24. [Enhancement of regulatory T cell induction by intravenous S-sulfonated Immunoglobulin during the treatment of experimental autoimmune encephalomyelitis].
Okuda S; Kamei S; Harano S; Shinya N; Hayashida K; Sasaki T
Yakugaku Zasshi; 2012; 132(2):243-9. PubMed ID: 22293707
[TBL] [Abstract][Full Text] [Related]
25. Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration.
Rosenkranz E; Maywald M; Hilgers RD; Brieger A; Clarner T; Kipp M; Plümäkers B; Meyer S; Schwerdtle T; Rink L
J Nutr Biochem; 2016 Mar; 29():116-23. PubMed ID: 26895672
[TBL] [Abstract][Full Text] [Related]
26. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand.
Ray A; Basu S; Williams CB; Salzman NH; Dittel BN
J Immunol; 2012 Apr; 188(7):3188-98. PubMed ID: 22368274
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Cdk8/Cdk19 Activity Promotes Treg Cell Differentiation and Suppresses Autoimmune Diseases.
Guo Z; Wang G; Lv Y; Wan YY; Zheng J
Front Immunol; 2019; 10():1988. PubMed ID: 31552016
[TBL] [Abstract][Full Text] [Related]
28. Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer.
Qu X; Cao YX; Xing YX; Liu Q; Li HJ; Yang WH; Wang BQ; Han SY; Wang YS
Clin Transl Oncol; 2023 Oct; 25(10):2772-2782. PubMed ID: 37095423
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway.
Dong P; Xiong Y; Konno Y; Ihira K; Kobayashi N; Yue J; Watari H
J Exp Clin Cancer Res; 2021 Jun; 40(1):216. PubMed ID: 34174908
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of M2 Macrophage-Derived Exosomal Long Non-coding RNA PVT1 in Regulating Th17 Cell Response in Experimental Autoimmune Encephalomyelitisa.
Wu L; Xia J; Li D; Kang Y; Fang W; Huang P
Front Immunol; 2020; 11():1934. PubMed ID: 33013847
[TBL] [Abstract][Full Text] [Related]
31. The lncRNA-DLEU2/miR-186-5p/PDK3 axis promotes the progress of glioma cells.
Xie Z; Li X; Chen H; Zeng A; Shi Y; Tang Y
Am J Transl Res; 2019; 11(8):4922-4934. PubMed ID: 31497209
[TBL] [Abstract][Full Text] [Related]
32. Cancer-related micropeptides encoded by ncRNAs: Promising drug targets and prognostic biomarkers.
Setrerrahmane S; Li M; Zoghbi A; Lv X; Zhang S; Zhao W; Lu J; Craik DJ; Xu H
Cancer Lett; 2022 Oct; 547():215723. PubMed ID: 35533953
[TBL] [Abstract][Full Text] [Related]
33. LncRNA DLEU2 is activated by STAT1 and induces gastric cancer development via targeting miR-23b-3p/NOTCH2 axis and Notch signaling pathway.
Li G; Zhang Z; Chen Z; Liu B; Wu H
Life Sci; 2021 Jul; 277():119419. PubMed ID: 33785336
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA DLEU2 predicts a poor prognosis and enhances malignant properties in laryngeal squamous cell carcinoma through the miR-30c-5p/PIK3CD/Akt axis.
Li X; Xu F; Meng Q; Gong N; Teng Z; Xu R; Zhao M; Xia M
Cell Death Dis; 2020 Jun; 11(6):472. PubMed ID: 32555190
[TBL] [Abstract][Full Text] [Related]
35. [Progress on sORF-encoded micropeptides].
Chen XY; Li MW; Wang Y; Chen Q; Xu HM
Yi Chuan; 2021 Aug; 43(8):737-746. PubMed ID: 34413014
[TBL] [Abstract][Full Text] [Related]
36. lncRNA DLEU2 Accelerates Oral Cancer Progression via miR-30a-5p/RAP1B Axis to Regulate p38 MAPK Signaling Pathway.
Zhang W; Wang Y; Xu P; Du Y; Guan W
Dis Markers; 2022; 2022():9310048. PubMed ID: 36277988
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA DLEU2 regulates the progression of Wilm's tumor via miR-539-3p/HOXB2 axis.
Yong J; He J; Ning F
J Pediatr Urol; 2023 Feb; 19(1):25-32. PubMed ID: 36209036
[TBL] [Abstract][Full Text] [Related]
38. Generation of RORγt
Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
[TBL] [Abstract][Full Text] [Related]
39. MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Wu L; Li N; Zhang M; Xue SL; Cassady K; Lin Q; Riggs AD; Zeng D
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15994-9. PubMed ID: 26647186
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription.
Salerno D; Chiodo L; Alfano V; Floriot O; Cottone G; Paturel A; Pallocca M; Plissonnier ML; Jeddari S; Belloni L; Zeisel M; Levrero M; Guerrieri F
Gut; 2020 Nov; 69(11):2016-2024. PubMed ID: 32114505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
